Centerbridge Partners’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,999
Closed -$3K 32
2022
Q3
$3K Hold
24,999
﹤0.01% 26
2022
Q2
$3K Hold
24,999
﹤0.01% 36
2022
Q1
$9K Hold
24,999
﹤0.01% 31
2021
Q4
$13K Hold
24,999
﹤0.01% 58
2021
Q3
$14K Sell
24,999
-2
-0% -$1 ﹤0.01% 56
2021
Q2
$18K Hold
25,001
﹤0.01% 63
2021
Q1
$12K Buy
+25,001
New +$14.5K ﹤0.01% 56

Other funds holding EQHA.WS

Centerbridge Partners's EQHA.WS Position: Q4 2022 in Review

Centerbridge Partners sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 24,999 shares — an estimated $3K sold.

Centerbridge Partners first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $18K in Q2 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Centerbridge Partners reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Centerbridge Partners sold 24,999 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $3K.
  • Centerbridge Partners first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
  • Centerbridge Partners's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $18K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Centerbridge Partners's 13F filing for Q4 2022, filed 14 Feb 2023.